July/August 2005 :: Vol 35 No 7/8
Clinical and prevention
Allred, N. J., Turner, J. C., David, F., DeLozier, D. M., and Strikas, R. A. (2005) Responses of US college and university student health services to the 2004 influenza vaccine shortage. Journal of American College Health. vol. 53(6), 291-4
Andrawiss, M. (2005) Flu pills for a pandemic threat. Drug Discovery Today. vol. 10(12), 811
Anonymous (2005) U.S. unprepared for flu outbreak, experts warn. Medicine and Health. vol. 59(19), 1, 5
Anonymous (2005) Who can give injections and IVs? Tennessee Medicine. vol. 98(3), 106-7
Asano, T., Sasaki, N., Yashiro, K., Hatori, T., Kuwabara, K., Hamada, H., Imai, T., and Fujino, O. (2005) Acute pancreatitis with Kawasaki disease: analysis of cases with elevated serum amylase levels. European Journal of Pediatrics. vol. 164(3), 180-1
Asia Pacific, C. R. G. (2005) Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. [Review] [27 refs]. Respirology. vol. 10(1), 9-17
Auckland, C., Cowlishaw, A., Morgan, D., and Miller, E. (2005) Reactions to small pox vaccine in naive and previously-vaccinated individuals. Vaccine. vol. 23(32), 4185-4187
Ayala-Montiel, O., Mascarenas, C., Garcia-Hernandez, D., Rendon-Muniz, J., Lopez, I., Felipe Montano, L., Zenteno, I., and Franco-Paredes, C. (2005) [Immunogenicity and safety of the influenza vaccine, in a population older than 55-years in Mexico]. [Spanish]. Salud Publica de Mexico. vol. 47(2), 155-62
Belov, A. B. and Ogarkov, P. I. (2005) [Epidemiology and prophylaxis of influenza and other acute respiratory infections occurred in the military collectives]. [Review] [14 refs] [Russian]. Voenno-Meditsinskii Zhurnal. vol. 326(3), 32-8, 80
Bembenek, A. (2005) [Could the fetus' exposure to influenza increase the risk of schizophrenia in adult life?]. [Polish]. Psychiatria Polska. vol. 39(2), 271-83
Brady, T. (2005) Fire and flu. Minnesota Medicine. vol. 88(1), 28-31
Burnett, M., Genao, I., and Wong, W. F. (2005) Race, culture, and trust: why should I take a shot if I'm not sick? Ethnicity and Disease. vol. 15(2 Suppl 3), S3-13-S3-6
Busby, A., Dolk, H., and Armstrong, B. (2005) Eye anomalies: seasonal variation and maternal viral infections. Epidemiology. vol. 16(3), 317-22
Carlsen, E. H. (2005) Flu-shot politics. Advance for Nurse Practitioners. vol. 13(5), 92
Centers for Disease Control and Prevention (CDC) (2005) Rapid assessment of influenza vaccination coverage among HMO members--northern California influenza seasons, 2001-02 through 2004-05. MMWR. Morbidity and Mortality Weekly Report. vol. 54(27), 676-8
Chand, P., Bantia, S., Kotian, P. L., El-Kattan, Y., Lin, T. H., and Babu, Y. S. (2005) Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo. Bioorganic and Medicinal Chemistry. vol. 13(12), 4071-4077
D'Alessandro, D., Rossini, A., Fara, G. M., and Ciriminna, S. (2005) Reactogenicity trends by age to influenza and pneumococcal vaccines.[comment]. Journal of the American Geriatrics Society. vol. 53(5), 910-1
De Filtte, M., Jou, W. M., Birkett, A., Lyons, K., Schultz, B., Tonkyro, A., Resch, S., and Fiers, W. (2005) Universal influenza A vaccine: Optimization of M2-based constructs. Virology. vol. 337(1), 149-161
De Marco, G., Ummarino, D., Giannetti, E., Magurno, T., and Guarino, A. (2005) Impact of mass communication in the implementation of influenza vaccination for infants.[comment]. Archives of Pediatrics and Adolescent Medicine. vol. 159(6), 596; author reply 596-7
De Menezes, R. X., Ortega, N. R., and Massad, E. (2004) A Reed-Frost model taking into account uncertainties in the diagnostic of the infection. Bulletin of Mathematical Biology. vol. 66(4), 689-706
De Serres, G., Toth, E., Menard, S., Grenier, J. L., Roussel, R., Tremblay, M., Landry, M., Robert, Y., Rochette, L., and Skowronski, D. M. (2005) Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons. Vaccine. vol. 23(28), 3726-3732
Desbiens, N. A. (2005) A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults. American Journal of Infection Control. vol. 33(4), 238-42
Desroches, C. M., Blendon, R. J., and Benson, J. M. (2005) Americans' responses to the 2004 influenza vaccine shortage. Health Affairs. vol. 24(3), 822-31
Drew, W. L. (2005) I wish to comment on several points in the recent "Guidelines".[comment]. Journal of Clinical Virology. vol. 33(1), 79
Eggertson, L. (2005) Canadian company to develop mock pandemic vaccine. Canadian Medical Association Journal/Journal de L'Association Medicale Canadienne. vol. 172(5), 623
Eggertson, L. (2005) Countries ill-prepared for influenza pandemic. Canadian Medical Association Journal/Journal de L'Association Medicale Canadienne. vol. 172(1), 23-4
Eggertson, L. (2005) Vaccinating the world: how likely? Canadian Medical Association Journal/Journal de L'Association Medicale Canadienne. vol. 172(1), 24
Farris, J. R. (2005) When insurance is not enough: racial and ethnic disparities in immunizations for the Medicare population. Ethnicity and Disease. vol. 15(2 Suppl 3), S3-7-S3-12
Fauci, A. S. (2005) Race against time. Nature. vol. 435(7041), 423-4
Fedson, D. S. (2005) Interview with David S. Fedson, MD, Former Professor of Medicine, University of Virginia School of Medicine, and Director of Medical Affairs, Aventis Pasteur MSD by Madeline Drexler. Biosecurity and Bioterrorism. vol. 3(1), 9-15
Fedson, D. S. (2005) Preparing for pandemic vaccination: an international policy agenda for vaccine development. Journal of Public Health Policy. vol. 26(1), 4-29
Fleming, D. M., Pannell, R. S., and Cross, K. W. (2005) Mortality in children from influenza and respiratory syncytial virus. Journal of Epidemiology and Community Health. vol. 59(7), 586-590
Fleming, D. M., Pannell, R. S., Elliot, A. J., and Cross, K. W. (2005) Respiratory illness associated with influenza and respiratory syncytial virus infection. Archives of Disease in Childhood. vol. 90(7), 741-746
Freedman, D. O. and Leder, K. (2005) Influenza: changing approaches to prevention and treatment in travelers. [Review] [54 refs]. Journal of Travel Medicine. vol. 12(1), 36-44
Gardner, E. M. (2005) Caloric restriction decreases survival of aged mice in response to primary influenza infection. Journals of Gerontology Series A-Biological Sciences and Medical Sciences. vol. 60(6), 688-694
Gardner, P. and Pabbatireddy, S. (2004) Vaccines for women age 50 and older. Emerging Infectious Diseases. vol. 10(11), 1990-5
Gendon, I. u. Z., Markushin, S. G., Akopova, I. I., Koptiaeva, I. B., Nechaeva, E. A., Mazurkova, I. A., Radaeva, I. F., and Kolokol'tsova, T. D. (2005) [Further development (MDCK) of live cold-adapted influenza vaccine: cultivation of vaccine strains in production fermenters]. [Russian]. Voprosy Virusologii. vol. 50(2), 4-9
Gordon, L. I. (2005) Flu redux and RIT: friendly fire in the treatment of low-grade lymphoma. Blood. vol. 105(12), 4543-4544
Gorelick, K. J. (2005) Respiratory syncytial virus infection in elderly adults.[comment]. New England Journal of Medicine. vol. 353(4), 422-3; author reply 422-3
Grau, A. J., Fischer, B., Barth, C., Ling, P., Lichy, C., and Buggle, F. (2005) Influenza vaccination is associated with a reduced risk of stroke. Stroke. vol. 36(7), 1501-1506
Greci, L. S., Katz, D. L., and Jekel, J. (2005) Vaccinations in pneumonia (VIP): pneumococcal and influenza vaccination patterns among patients hospitalized for pneumonia. Preventive Medicine. vol. 40(4), 384-8
Hasejima, N., Yamato, K., Takezawa, S., Kobayashi, H., and Kadoyama, C. (2005) Invasive pulmonary aspergillosis associated with influenza B. [Review] [15 refs]. Respirology. vol. 10(1), 116-9
Hasle, G. (2005) [Private hoarding of influenza vaccine]. [Norwegian]. Tidsskrift for Den Norske Laegeforening. vol. 125(13), 1883; author reply 1883-4
Heikkinen, T. and Ruuskanen, O. (2005) Influenza vaccines in healthy children. Lancet. vol. 365(9477), 2086-2087
Hosoya, M., Nunoi, H., Aoyama, M., Kawasaki, Y., and Suzuki, H. (2005) Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatric Infectious Disease Journal. vol. 24(5), 467-70
Humiston, S. G. (2005) Impact of mass communication in the implementation of influenza vaccination for infants - In reply. Archives of Pediatrics and Adolescent Medicine. vol. 159(6), 596-597
Iglehart, J. K. (2005) Financing vaccines: in search of solutions that work.[comment]. Health Affairs. vol. 24(3), 594-5
Inamatsu, T., Masuda, Y., Kosugi, Y., Adachi, K., and Hino, Y. (2005) [Strategy for influenza in the aged]. [Japanese]. Nippon Ronen Igakkai Zasshi - Japanese Journal of Geriatrics. vol. 42(3), 288-90
Jefferson, T., Smith, S., Demicheli, V., Harnden, A., and Rivetti, A. (2005) Influenza vaccines in healthy children - Reply. Lancet. vol. 365(9477), 2087
Jennings, L. (2005) New Zealand's preparedness for the next influenza pandemic.[comment]. New Zealand Medical Journal. vol. 118(1211), U1343
Jimenez-Garcia, R., Arinez-Fernandez, M. C., Garcia-Carballo, M., Hernandez-Barrera, V., De Miguel, A. G., and Carrasco-Garrido, P. (2005) Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine. vol. 23(28), 3679-3686
Kawashima, H., Amaha, M., Ioi, H., Yamanaka, G., Kashiwagi, Y., Sasamoto, M., Takekuma, K., Hoshika, A., and Watanabe, Y. (2005) Nitrite/Nitrate (NOx) and zinc concentrations in influenza-associated encephalopathy in children with different sequela. Neurochemical Research. vol. 30(3), 311-314
Keene, O. (2005) Design and analysis of trials with rare outcomes: Examples from trials in herpes transmission and influenza prophylaxis. Contemporary Clinical Trials. vol. 26(3), 311-322
Kibble, A. (2005) 18th International Conference on Antiviral Research. Respiratory viruses. Idrugs. vol. 8(6), 465-6
Kikawada, M., Iwamoto, T., and Takasaki, M. (2005) Aspiration and infection in the elderly : epidemiology, diagnosis and management. [Review] [112 refs]. Drugs and Aging. vol. 22(2), 115-30
Kojimahara, N., Maeda, A., and Yamaguchi, N. (2005) [Cross-induction of HI antibody against A (H3N2) of influenza HA vaccine]. [Japanese]. Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases. vol. 79(5), 348-9
Kumar, P., Khanna, M., Srivastava, V., Tyagi, Y. K., Raj, H. G., and Ravi, K. (2005) Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection. Experimental Lung Research. vol. 31(5), 449-459
Landi, F., Onder, G., Carpenter, I., Garms-Homolova, V., and Bernabei, R. (2005) Prevalence and predictors of influenza vaccination among frail, community-living elderly patients: an international observational study. Vaccine. vol. 23(30), 3896-901
Ljungman, P., Nahi, H., and Linde, A. (2005) Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. British Journal of Haematology. vol. 130(1), 96-98
Machado, C. M. (2005) Influenza infections after hematopoietic stem cell transplantation. Clinical Infectious Diseases. vol. 41(2), 273-274
Mah, M. W., Hagen, N. A., Pauling-Shepard, K., Hawthorne, J. S., Mysak, M., Lye, T., and Louie, T. J. (2005) Understanding influenza vaccination attitudes at a Canadian cancer center. American Journal of Infection Control. vol. 33(4), 243-50
Malaspina, A., Moir, S., Orsega, S. M., Vasquez, J., Miller, N. J., Donoghue, E. T., Kottilil, S., Gezmu, M., Follmann, D., Vodeiko, G. M., Levandowski, R. A., Mican, J. M., and Fauci, A. S. (2005) Compromised B cell responses to influenza vaccination in HIV-infected individuals. Journal of Infectious Diseases. vol. 191(9), 1442-50
McKimm-Breschkin, J. L. (2005) Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. [Review] [81 refs]. Treatments in Respiratory Medicine. vol. 4(2), 107-16
Miller, H. I. (2005) Vaccines--why the US government must act.[comment]. Nature Biotechnology. vol. 23(3), 287
Mitka, M. (2005) Preparing for flu season. JAMA-Journal of the American Medical Association. vol. 293(22), 2709
Mohan, S. S., Nair, V., and Cunha, B. A. (2005) Post-viral influenza Streptococcus pneumoniae pneumonia in an intravenous drug abuser. Heart and Lung. vol. 34(3), 222-6
Morishima, T. (2005) [Influenza-associated encephalopathy]. [Review] [13 refs] [Japanese]. Nippon Rinsho - Japanese Journal of Clinical Medicine. vol. 63(Suppl. 4), 521-7
Mosesso, V. N. Jr., Packer, C. R., McMahon, J., Auble, T. E., and Paris, P. M. (2003) Influenza immunizations provided by EMS agencies: the MEDICVAX Project. Prehospital Emergency Care. vol. 7(1), 74-8
National Advisory Committee on Immunization, N. (2005) Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement. Canada Communicable Disease Report - Releve des Maladies Transmissibles au Canada. vol. 31(ACS-6), 1-30
Neuraminidase Inhibitor Susceptibility Network (2005) Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance. Weekly Epidemiological Record. vol. 80(17), 156
Nordstrom, B. L., Sung, I., Suter, P., and Szneke, P. (2005) Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Current Medical Research and Opinion. vol. 21(5), 761-8
Okamoto, S., Kamiya, I., Kishida, K., Shimakawa, T., Fukui, T., and Morimoto, T. (2005) Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatric Infectious Disease Journal. vol. 24(6), 575-6
Osterholm, M. T. (2005) A weapon the world needs. Nature. vol. 435(7041), 417-8
Peltola, V. T., Murti, K. G., and Mccullers, J. A. (2005) Influenza virus neuraminidase contributes to secondary bacterial pneumonia. Journal of Infectious Diseases. vol. 192(2), 249-257
Posthouwer, D., Voorbij, H. A., Grobbee, D. E., Numans, M. E., and van der Bom. J. G. (2004) Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation. Vaccine. vol. 23(3), 362-5
Praditsuwan, R., Assantachai, P., Wasi, C., Puthavatana, P., and Kositanont, U. (2005) The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. Journal of the Medical Association of Thailand. vol. 88(2), 256-64
Puig-Barbera, J., Diez-Domingo, J., Perez Hoyos, S., Belenguer Varea, A., and Gonzalez Vidal, D. (2004) Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine. vol. 23(3), 283-9
Pyhala, R. (2004) [The world prepares for influenza epidemics]. [Finnish]. Duodecim. vol. 120(22), 2613-4
Ranieri, R., Veronelli, A., Santambrogio, C., and Pontiroli, A. E. (2005) Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. Aids Research and Human Retroviruses. vol. 21(5), 407-409
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., and France, E. K. (2005) Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. vol. 116(1), 153-159
Rust, G., Strothers, H. S. 3rd, and Zimmerman, R. K. (2005) Re-engineering the primary care practice to eliminate adult immunization disparities. [Review] [42 refs]. Ethnicity and Disease. vol. 15(2 Suppl 3), S3-21-S3-6
Sambamoorthi, U. and Findley, P. A. (2005) Who are the elderly who never receive influenza immunization? Preventive Medicine. vol. 40(4), 469-78
Satcher, D. (2005) Adult immunization disparities: a challenge for the public health/primary care partnership. Ethnicity and Disease. vol. 15(2 Suppl 3), S3-1-S3-3
Schaberg, T. (2005) [Prevention of infections of the lower respiratory tract in adults]. [German]. Pneumologie. vol. 59(4), 248-59; quiz 260-3
Sheridan, C. (2005) Flu virus lapses shows quantum leap in technologies needed - Developing treatments that would calm pandemic fears need more funding and resources. Nature Reviews Drug Discovery. vol. 4(6), 447
Simonsen, L. and Viboud, C. (2005) Respiratory syncytial virus infection in elderly adults.[comment]. New England Journal of Medicine. vol. 353(4), 422-3; author reply 422-3
Sinclair, M. (2004) Leaders emphasize basics in light of flu vaccine shortage. Contemporary Long-Term Care. vol. 23, 10-2
Stein, M., Yossepowitch, O., and Somekh, E. (2005) Influenza vaccine coverage in paediatric population from central Israel. Journal of Infection. vol. 50(5), 382-385
Stipp, D. (2005) 25 breakout companies--biotech: Crucell. Fortune. vol. 151(10), 155, 158
Swayne, D. E. (2004) Application of new vaccine technologies for the control of transboundary diseases. [Review] [29 refs]. Developments in Biologicals. vol. 119, 219-28
Tan, S. B., Goh, C., Thumboo, J., Che, W., Chowbay, B., and Cheung, Y. B. (2005) Risk perception is affected by modes of risk presentation among Singaporeans. Annals of the Academy of Medicine, Singapore. vol. 34(2), 184-7
Taylor, J. L., Roup, B. J., Blythe, D., Reed, G. K., Tate, T. A., and Moore, K. A. (2005) Pandemic influenza preparedness in Maryland: improving readiness through a tabletop exercise. Biosecurity and Bioterrorism. vol. 3(1), 61-9
Triggle, D. J. (2005) Vaccines, viagra, and vioxx: Medicines, markets, and money-when life-saving meets life-style. Drug Development Research. vol. 64(2), 90-98
Tsai, M. Y., Hanson, N. Q., Straka, R. J., Hoke, T. R., Ordovas, J. M., Peacock, J. M., Arends, V. L., and Arnett, D. K. (2005) Effect of influenza vaccine on markers of inflammation and lipid profile. Journal of Laboratory and Clinical Medicine. vol. 145(6), 323-7
Ursano, R. J. (2005) Preparedness for SARS, influenza, and bioterrorism.[comment]. Psychiatric Services. vol. 56(1), 7
Verweij, M. F. and van den Hoven, M. A. (2005) Influenza vaccination in Dutch nursing homes: is tacit consent morally justified? Medicine, Health Care and Philosophy. vol. 8(1), 89-95
Walden, J. (2005) Travel immunizations: benefits and precautions.[comment]. American Family Physician. vol. 71(12), 2254
Wiwanitkit, V. (2005) Platelet count in reported cases of bird flu infection in Thailand. Platelets. vol. 16(3-4), 227
Wortley, P. (2005) Who's getting shots and who's not: racial/ethnic disparities in immunization coverage. Ethnicity and Disease. vol. 15(2 Suppl 3), S3-4-S3-6
Epidemiology
Abbott, A. (2005) Avian flu special: what's in the medicine cabinet? Nature. vol. 435(7041), 407-9
Ahmed, F., Janes, G. R., Baron, R., Latts, L. M., and first Colorado Anthem Blue Cross and Blue Shield Team (2005) Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions. Journal of Clinical Epidemiology. vol. 58(6), 624-8
Al Faress, S., Cartet, G., Ferraris, O., Norder, H., Valette, M., and Lina, B. (2005) Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002. Journal of Clinical Virology. vol. 33(3), 230-6
Anonymous (2005) [Influenza pandemic planning. National influenza pandemic plan]. [German]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. vol. 48(3), 356-90
Anonymous (2005) On a wing and a prayer. Nature. vol. 435(7041), 385-6
Ansaldi, F., Icardi, G., Gasparini, R., Campello, C., Puzelli, S., Bella, A., Donatelli, I., Salmaso, S., and Crovari, P. (2005) New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season. Journal of Clinical Microbiology. vol. 43(6), 3027-3029
Barr, I. G., Komadina, N., Hurt, A. C., Iannello, P., Tomasov, C., Shaw, R., Durrant, C., Sjogren, H., and Hampson, A. W. (2005) An influenza A(H3) reassortant was epidemic in Australia and New Zealand in 2003. Journal of Medical Virology. vol. 76(3), 391-397
Bragstad, K., Jorgensen, P. H., Handberg, K. J., Mellergaard, S., Corbet, S., and Fomsgaard, A. (2005) New avian influenza A virus subtype combination H5N7 identified in Danish mallard ducks. Virus Research. vol. 109(2), 181-90
Butler, D. (2005) Bird flu: crossing borders. Nature. vol. 436(7049), 310-311
Butler, D. (2005) China rejects internet claims of human cases. Nature. vol. 435(7042), 542-3
Butler, D. (2005) Flu officials pull back from raising global alert level. Nature. vol. 436(7047), 6-7
Butler, D. (2005) Infected birds poised to take flu virus south. Nature. vol. 436(7047), 6
Centers for Disease Control and Prevention (CDC) (2005) Update: Influenza activity--United States and worldwide, 2004-05 season. MMWR. Morbidity and Mortality Weekly Report. vol. 54(25), 631-4
Chen, H., Smith, G. J., Zhang, S. Y., Qin, K., Wang, J., Li, K. S., Webster, R. G., Peiris, J. S., and Guan, Y. (2005) Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature. vol. 436(7048), 191-2
Cohen, J. M., Mosnier, A., Valette, M., Bensoussan, J. L., Van Der WerfS. , and GROG-I (2005) [General practice and surveillance: the example of influenza in France]. [French]. Medecine et Maladies Infectieuses. vol. 35(5), 252-6
Cyranoski, D. (2005) Asian nations struggle to keep up with bird flu surveillance. Nature Medicine. vol. 11(6), 582
Cyranoski, D. (2005) Avian flu special: masking our ignorance. Nature. vol. 435(7041), 408
Cyranoski, D. (2005) China's chicken farmers under fire for antiviral abuse. Nature. vol. 435(7045), 1009
Enserink, M. (2005) Avian influenza. Pandemic influenza: global update. Science. vol. 309(5733), 370-1
Enserink, M. (2005) Pandemic influenza - Global update. Science. vol. 309(5733), 370-71
Franco-Paredes, C., Tellez, I., del Rio, C., and Santos-Preciado, J. I. (2005) [The influenza pandemic: potential impact of aviary influenza]. [Spanish]. Salud Publica de Mexico. vol. 47(2), 107-9
Ho, D. (2005) Is China prepared for microbial threats? Nature. vol. 435(7041), 421-2
Jones, E. W. (2005) "Co-operation in All Human Endeavour": quarantine and immigrant disease vectors in the 1918-1919 influenza pandemic in Winnipeg. Canadian Bulletin of Medical History/Bulletin Canadien d'Histoire de la Medecine. vol. 22(1), 57-82
Khamsi, R. (2005) Avian flu special: deadly combinations. Nature. vol. 435(7041), 406
Kiseleva, I. V., Klimov, A. I., Grigor'eva, E. P., Larionova, N. V., Aleksandrova, G. I., and Rudenko, L. G. (2005) [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. [Russian]. Voprosy Virusologii. vol. 50(2), 14-8
Koplan, J. P. and McPheeters, M. (2004) Plagues, public health, and politics. Emerging Infectious Diseases. vol. 10(11), 2039-43
Kurth, B. M. (2005) [Correlation between an influenza pandemic plan and a plan for health monitoring]. [German]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. vol. 48(3), 259-60
Lange, C., Schutt, M., and Brodt, H. R. (2005) [Emerging respiratory infections caused by pneumotropic viruses]. [Review] [50 refs] [German]. Deutsche Medizinische Wochenschrift. vol. 130(22), 1385-91
Lemon, S. M. and Mahmoud, A. A. (2005) The threat of pandemic influenza: are we ready?. [Review] [26 refs]. Biosecurity and Bioterrorism. vol. 3(1), 70-3
Lipley, N. (2005) Preparing for a pandemic. Emergency Nurse. vol. 13(1), 5
Lu, J. H., Liu, X. F., Shao, W. X., Liu, Y. L., Wei, D. P., and Liu, H. Q. (2005) Phylogenetic analysis of eight genes of H9N2 subtype influenza virus: A Mainland China strain possessing early isolates' genes that have been circulating. Virus Genes. vol. 31(2), 163-169
Normile, D. (2005) Avian influenza - Chinese ministry questions bird flu findings. Science. vol. 309(5733), 364
Normile, D. (2005) Avian influenza - Potentially more lethal variant hits mieratory birds in China. Science. vol. 309(5732), 231
Normile, D. (2005) Avian influenza. Vietnam battles bird flu ... and critics. Science. vol. 309(5733), 368-73
Normile, D. and Enserink, M. (2005) Infectious diseases. Lapses worry bird flu experts. Science. vol. 308(5730), 1849-51
Reiter, S. and Haas, W. (2005) [Influenza pandemic: A real threat ?]. [German]. MMW Fortschritte der Medizin. vol. 147(9), 35-8
Schmidt, R. and Gierl, L. (2005) A prognostic model for temporal courses that combines temporal abstraction and case-based reasoning. International Journal of Medical Informatics. vol. 74(2-4), 307-15
Schroder, K. T. (2005) [The influenza pandemic plan]. [German]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. vol. 48(3), 257-8
Shinya, K., Hatta, M., Yamada, S., Takada, A., Watanabe, S., Halfmann, P., Horimoto, T., Neumann, G., Kim, J. H., Lim, W., Guan, Y., Peiris, M., Kiso, M., Suzuki, T., Suzuki, Y., and Kawaoka, Y. (2005) Characterization of a human H5N1 influenza A virus isolated in 2003. Journal of Virology. vol. 79(15), 9926-9932
Stephenson, J. (2005) Avian flu concerns. JAMA-Journal of the American Medical Association. vol. 293(23), 2850
Turner, J., Clothier, H. J., and Kaye, M. (2005) Influenza surveillance in Victoria, 2004. Communicable Diseases Intelligence. vol. 29(1), 71-6
Viboud, C., Grais, R. F., Lafont, B. A. P., Miller, M. A., Simonsen, L., and Multinational Influenza Seasonal M (2005) Multinational impact of the 1968 Hong Kong influenza pandemic: Evidence for a smoldering pandemic. Journal of Infectious Diseases. vol. 192(2), 233-248
Wilson, N., Mansoor, O., and Baker, M. (2005) Estimating the impact of the next influenza pandemic on population health and health sector capacity in New Zealand.[see comment]. New Zealand Medical Journal. vol. 118(1211), U1346
Immunology
Amacker, M., Engler, O., Kammer, A. R., Vadrucci, S., Oberholzer, D., Cerny, A., and Zurbriggen, R. (2005) Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells. International Immunology. vol. 17(6), 695-704
Antrobus, R. D., Khan, N., Hislop, A. D., Montamat-Sicotte, D., Garner, L. I., Rickinson, A. B., Moss, P. A., and Willcox, B. E. (2005) Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. Journal of Infectious Diseases. vol. 191(11), 1842-53
Bernasconi, D., Amici, C., La Frazia, S., Ianaro, A., and Santoro, M. G. (2005) The I k B kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. Journal of Biological Chemistry. vol. 280(25), 24127-24134
Bizanov, G., Janakova, L., Knapstad, S. E., Karlstad, T., Bakke, H., Haugen, I. L., Haugan, A., Samdal, H. H., and Haneberg, B. (2005) Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness. Scandinavian Journal of Immunology. vol. 61(6), 503-10
Crouch, C. F., Daly, J., Hannant, D., Wilkins, J., and Francis, M. J. (2004) Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus. Vaccine. vol. 23(3), 418-25
Cárdenas, C., Villaveces, J. L., Suárez, C., Obregón, M., Ortiz, M., and Patarroyo, M. E. (2005) A comparative study of MHC Class-II HLA-DRb1*0401-Col II and HLA-DRb1*0101-HA complexes: a theoretical point of view. Journal of Structural Biology. vol. 149(1), 38-52
Davidson, B. A., Stewart, C. C., Russo, T. A., Chess, P. R., and Knight, P. R. 3rd (2005) Discrimination of resident and infiltrated alveolar macrophages by flow cytometry in influenza A virus-infected mice. Experimental Lung Research. vol. 31(3), 323-39
Ibegbu, C. C., Xu, Y. X., Harris, W., Maggio, D., Miller, J. D., and Kourtis, A. P. (2005) Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. Journal of Immunology. vol. 174(10), 6088-94
Kohut, M. L., Lee, W., Martin, A., Arnston, B., Russell, D. W., Ekkekakis, P., Yoon, K. J., Bishop, A., and Cunnick, J. E. (2005) The exercise-induced enhancement of influenza immunity is mediated in part by improvements in psychosocial factors in older adults. Brain Behavior and Immunity. vol. 19(4), 357-366
Liu, W., Peng, Z., Liu, Z., Lu, Y., Ding, J., and Chen, Y. H. (2004) High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine. vol. 23(3), 366-71
Marsland, B. J., Schmitz, N., and Kopf, M. (2005) IL-4Ralpha signaling is important for CD8+ T cell cytotoxicity in the absence of CD4+ T cell help. European Journal of Immunology. vol. 35(5), 1391-8
Noone, C. M., Lewis, E. A., Frawely, A. B., Newman, R. W., Mahon, B. P., Mills, K. H., and Johnson, P. A. (2005) Novel mechanism of immunosuppression by influenza virus haemagglutinin: selective suppression of interleukin 12 p35 transcription in murine bone marrow-derived dendritic cells. Journal of General Virology. vol. 86(Pt 7), 1885-90
Patke, D. S. and Farber, D. L. (2005) Modulation of memory CD4 T cell function and survival potential by altering the strength of the recall stimulus. Journal of Immunology. vol. 174(9), 5433-43
Prakash, A., Smith, E., Lee, C. K., and Levy, D. E. (2005) Tissue-specific positive feedback requirements for production of type I interferon following virus infection. Journal of Biological Chemistry. vol. 280(19), 18651-7
Price, G. E., Huang, L., Ou, R., Zhang, M. H., and Moskophidis, D. (2005) Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8(+)-T-cell escape variants of influenza virus. Journal of Virology. vol. 79(13), 8545-8559
Seneviratne, S. L., Jones, L., Bailey, A. S., Samuel, R. V., Black, A. P., and Ogg, G. S. (2005) Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection. Clinical and Experimental Immunology. vol. 141(1), 107-15
Sergeev, A. N., P'iankov, O. V., Shishkina, L. N., Duben', L. G., Petrishchenko, V. A., Zhukov, V. A., P'iankova, O. G., Sviatchenko, L. I., Sherstoboev, E. I. u., Karimova, T. V., Martiushev-Poklad, A. V., Sergeeva, S. A., Epshtein, O. I., Glotov, A. G., and Glotova, T. I. (2004) [Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice]. [Russian]. Antibiotiki i Khimioterapiia. vol. 49(11), 7-11
Suarez Butler, M. F., Langkamp-Henken, B., Herrlinger-Garcia, K. A., Klash, A. E., Szczepanik, M. E., Nieves, C. Jr, Cottey, R. J., and Bender, B. S. (2005) Arginine supplementation enhances mitogen-induced splenocyte proliferation but does not affect in vivo indicators of antigen-specific immunity in mice. Journal of Nutrition. vol. 135(5), 1146-50
Wareing, M. D., Harrison, L. C., and Tannock, G. A. (2005) Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza - A vaccine donor strains. Vaccine. vol. 23(31), 4075-4081
Williams, A. E., Humphreys, I. R., Cornere, M., Edwards, L., Rae, A., and Hussell, T. (2005) TGF-b prevents eosinophilic lung disease but impairs pathogen clearance. Microbes and Infection. vol. 7(3), 365-74
Zammit, D. J., Cauley, L. S., Pham, Q. M., and Lefrancois, L. (2005) Dendritic cells maximize the memory CD8 T cell response to infection. Immunity. vol. 22(5), 561-70
Zanvit, P., Havlickova, M., Tacner, J., Jirkovska, M., Petraskova, P., Novotna, O., Cechova, D., Julak, J., Sterzl, I., and Prokesova, L. (2005) Immune response after adjuvant mucosal immunization of mice with inactivated influenza virus. Immunology Letters. vol. 97(2), 251-9
Structure, function and genetics
Chang, D. K., Cheng, S. F., Lin, C. H., Kantchev, E. A. B., and Wu, C. W. (2005) Self-association of glutamic acid-rich fusion peptide analogs of influenza hemagglutinin in the membrane-mimic environments: Effects of positional difference of glutamic acids on side chain ionization constant and intra- and inter-peptide interactions deduced from NMR and gel electrophoresis measurements. Biochimica Et Biophysica Acta-Biomembranes. vol. 1712(1), 37-51
Cohen, B., Dafni, H., Meir, G., Harmelin, A., and Neeman, M. (2005) Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia (New York). vol. 7(2), 109-17
del Carmen Fernandez-Alonso, M., Canada, F. J., Jimenez-Barbero, J., and Cuevas, G. (2005) Molecular recognition of saccharides by proteins. Insights on the origin of the carbohydrate-aromatic interactions. Journal of the American Chemical Society. vol. 127(20), 7379-86
Deng, T., Sharps, J., Fodor, E., and Brownlee, G. G. (2005) In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex. Journal of Virology. vol. 79(13), 8669-8674
Hess, S. T., Kumar, M., Verma, A., Farrington, J., Kenworthy, A., and Zimmerberg, J. (2005) Quantitative electron microscopy and fluorescence spectroscopy of the membrane distribution of influenza hemagglutinin. Journal of Cell Biology. vol. 169(6), 965-976
Krell, T., Manin, C., Nicolai, M. C., Pierre-Justin, C., Berard, Y., Brass, O., Gerentes, L., Leung-Tack, P., and Chevalier, M. (2005) Characterization of different strains of poliovirus and influenza virus by differential scanning calorimetry. Biotechnology and Applied Biochemistry. vol. 41, 241-246
Li, Z. N., Mueller, S. N., Ye, L., Bu, Z. G., Yang, C. L., Ahmed, R., and Steinhauer, D. A. (2005) Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: Protein characterization, incorporation into infectious influenza viruses, and antigenicity. Journal of Virology. vol. 79(15), 10003-10012
Lugovtsev, V. Y., Vodeiko, G. M., and Levandowski, R. A. (2005) Mutational pattern of influenza B viruses adapted to high growth replication in embryonated eggs. Virus Research. vol. 109(2), 149-57
Maring, C. J., Stoll, V. S., Zhao, C., Sun, M. H., Krueger, A. C., Stewart, K. D., Madigan, D. L., Kati, W. M., Xu, Y. B., Carrick, R. J., Montgomery, D. A., Kempf-Grote, A., Marsh, K. C., Molla, A., Steffy, K. R., Sham, H. L., Laver, W. G., Gu, Y. G., Kempf, D. J., and Kohlbrenner, W. E. (2005) Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors. Journal of Medicinal Chemistry. vol. 48(12), 3980-3990
Misono, T. S. and Kumar, P. K. R. (2005) Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance. Analytical Biochemistry. vol. 342(2), 312-317
Quinlivan, M., Zamarin, D., Garcia-Sastre, A., Cullinane, A., Chambers, T., and Palese, P. (2005) Attenuation of equine influenza viruses through truncations of the NS1 protein. Journal of Virology. vol. 79(13), 8431-8439
Radaeva, I. F., Kolokol'tsova, T. D., Nechaeva, E. A., Mazurkova, N. A., Il'ina, T. V., Getmanova, T. N., Baltueva, L. S., Grafodatskii, A. S., Gendon, I. u. Z., and Petruchuk, E. M. (2005) [Development and certification of libraries of the MDCK continuous cell line for production of influenza vaccine]. [Russian]. Voprosy Virusologii. vol. 50(2), 43-6
Rimmelzwaan, G. F., Berkhoff, E. G. M., Nieuwkoop, N. J., Smith, D. J., Fouchier, R. A. M., and Osterhaus, A. D. M. E. (2005) Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants. Journal of General Virology. vol. 86, 1801-1805
Shinya, K., Suto, A., Kawakami, M., Sakamoto, H., Umemura, T., Kawaoka, Y., Kasai, N., and Ito, T. (2005) Neurovirulence of H7N7 influenza A virus: Brain stem encephalitis accompanied with aspiration pneumonia in mice. Archives of Virology. vol. 150(8), 1653-1660
Souriau, C., Chiche, L., Irving, R., and Hudson, P. (2005) New binding specificities derived from Min-23, a small cystine-stabilized peptidic scaffold. Biochemistry. vol. 44(19), 7143-55
Stech, J., Garn, H., Wegmann, M., Wagner, R., and Klenk, H. D. (2005) A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nature Medicine. vol. 11(6), 683-689
Teske, S., Bohn, A. A., Regal, J. F., Neumiller, J. J., and Lawrence, B. P. (2005) Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. American Journal of Physiology - Lung Cellular & Molecular Physiology. vol. 289(1), L111-24
Turpin, E., Luke, K., Jones, J., Tumpey, T., Konan, K., and Schultz-Cherry, S. (2005) Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. Journal of Virology. vol. 79(14), 8802-11
Uchide, N., Ohyama, K., Bessho, T., and Toyoda, H. (2005) Inhibition of influenza-virus-induced apoptosis in chorion cells of human fetal membranes by nordihydroquaiaretic acid. Intervirology. vol. 48(5), 336-340
Venkataraman, P., Lamb, R. A., and Pinto, L. H. (2005) Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of influenza A virus. Journal of Biological Chemistry. vol. 280(22), 21463-21472
Wallensten, A., Munster, V. J., Elmberg, J., Osterhaus, A. D. M. E., Fouchier, R. A. M., and Olsen, B. (2005) Multiple gene segment reassortment between Eurasian and American lineages of influenza A virus (H6N2) in Guillemot (Uria aalge). Archives of Virology. vol. 150(8), 1685-1692
Wu, G. A. and Yan, S. M. (2005) Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino-acid pair and fast Fourier transform. Biochemical and Biophysical Research Communications. vol. 333(1), 70-78
Yamamoto, N. and Urade, M. (2005) Pathogenic signiticance of a-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus. Microbes and Infection. vol. 7(4), 674-681
Yang, Z. C., Wang, B. C., Yang, X. S., and Wang, Q. (2005) Chemical composition of the volatile oil from Cynanchum stauntonii and its activities of anti-influenza virus. Colloids and Surfaces B-Biointerfaces. vol. 43(3-4), 198-202
Zaitseva, E., Mittal, A., Griffin, D. E., and Chernomordik, L. V. (2005) Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. Journal of Cell Biology. vol. 169(1), 167-77